Follow-The-Filings

Security · featured owners

IDYA Ideaya Biosciences Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 3.5%
  • $19M
  • 1 add

Who owns this now

Largest portfolio weights among featured holders · max 3.5% (Nathan Fischel - Dafna Ca...) · not free-float ownership

  1. Nathan Fischel add 3.5%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 3.5% Add +4.3% 497,240 $19M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $23.38M $7M $218.71M
Net income -$112.96M -$274.48M -$113.7M
Net margin * -483.0% -3921.1% -52.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $532.63M $689.71M $666.73M
Total non-current assets * $116.68M $434.38M $442.6M
Total assets $649.32M $1.12B $1.11B
Total current liabilities $27.1M $46.07M $58.82M
Total non-current liabilities * $1.12M $18.87M $27.58M
Total equity $621.09M $1.06B $1.02B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$115.22M -$247.58M -$71.1M
Cash from investing -$158.46M -$502.56M $69.98M
Cash from financing $362.72M $677.55M $29.78M
Net change in cash $89.04M -$72.59M $28.66M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders